Although an effective COVID-19 vaccine could be the proximal solution to the SARS-CoV-2, genetic diversity in the S protein and its implication in host immune evasion must be taken into account in order to develop improved vaccines in the future, which may be required to protect against new mutations. The gene discussed is PROS1; the disease is COVID-19.